Epigenetics Market by Application, Product, and Geography - Forecast and Analysis 2023-2027
- Published: Mar 2023
- Pages: 163
- SKU: IRTNTR75055
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The epigenetics market is estimated to grow at a CAGR of 14.06% between 2022 and 2027. The size of the market is forecasted to increase by USD 1,148.2 million. The growth of the market depends on several factors, including rising epigenetic applications in non-oncology diseases, increasing prevalence of CVDs, and the increase in strategic collaboration and M&A.
This report extensively covers market segmentation by application (oncology and non-oncology), product (reagents, kits, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
What will be the Size of the Epigenetics Market During the Forecast Period?
To learn more about this report, Download Report Sample
Epigenetics Market: Key Drivers, Trends, Challenges, and Customer Landscape
The increasing prevalence of CVDs is notably driving the market growth, although factors such as an unfavorable reimbursement scenario may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Epigenetics Market Driver
- The increasing prevalence of CVDs is notably driving the epigenetics market growth.
- The prevalence of CVDs is estimated to be equal among men and women across different countries.
- Low awareness, especially in the growing economies of Asia, is one of the primary reasons for the spread of CVDs.
- Smoking, high cardiac rhythm, atherosclerosis, diabetes, and high cholesterol are other risk factors contributing to the prevalence of CVDs.
- Epigenetics solutions are needed to treat CVD patients, which, in turn, is expected to increase their demand during the forecast period.
Significant Epigenetics Market Trend
- The rising number of genome projects is a key trend influencing the epigenetics market growth.
- The number of genome projects undertaken by researchers and scientists has increased in recent years.
- For example, the Human Genome Project (HGP), coordinated by the National Institutes of Health (NIH) and the US Department of Energy, was an international research project aimed at determining the sequence of the human genome.
- Such projects help researchers understand the functions of genes and proteins, which play a major role in the fields of medicine, biotechnology, and life sciences.
- Researchers, scientists, and clinicians use epigenetics solutions to study the role of DNA and genes that cause complex diseases.
- Thus, the increasing focus of researchers and scientists on genome projects is increasing the adoption of epigenetics solutions for applications such as DNA sequencing, which will support market growth during the forecast period.
Major Epigenetics Market Challenge
- An unfavorable reimbursement scenario may impede the epigenetics market growth.
- Patients are unable to take full advantage of genetic tests, as payers such as insurance companies and Medicare do not have a well-established and systematic approach to reimbursements.
- As a result, insurers face challenges in deciding whether genetic tests should be eligible for reimbursements.
- Genetic testing procedures are billed according to a standardized system of current procedural terminology codes developed by the American Medical Association (AMA). However, the identification of the tests and the associated billing are complex.
- The limited data available for evaluating the economics of genetic testing makes it difficult for insurers to determine the tests to be reimbursed and the appropriate circumstances.
- Hence, an unfavorable reimbursement scenario for genome sequencing will impede the growth of the global epigenetics market during the forecast period.
Key Epigenetics Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Epigenetics Market Customer Landscape
Who are the Major Epigenetics Market Vendors?
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Bio Rad Laboratories Inc. - The company offers epigenetic analysis research, which involves study alterations in DNA methylation, DNA protein interactions, chromatin accessibility, and histone modifications.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
- Abcam plc
- Active Motif Inc.
- Agilent Technologies Inc.
- Bio Techne Corp.
- BioVision Inc.
- CellCentric Ltd.
- Enzo Biochem Inc.
- EpiGentek Group Inc.
- F. Hoffmann La Roche Ltd.
- Hologic Inc.
- Illumina Inc.
- Merck KGaA
- New England Biolabs Inc.
- Pacific Biosciences of California Inc.
- Perkin Elmer Inc.
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
What are the Fastest-Growing Segments in the Epigenetics Market?
The market share growth by the oncology segment will be significant during the forecast period. The increasing prevalence of cancer will increase the adoption of epigenetics. Cancer is caused by a variety of factors, including genetics, lifestyle choices, and exposure to certain environmental factors. Epigenetics solutions help in identifying diseases such as cancer.
Get a glance at the market contribution of various segments Request a PDF Sample
The oncology segment was valued at USD 433.60 million in 2017 and continued to grow by 2021. Many researchers are working on identifying and categorizing epigenetic patterns linked to cancer, and each identified change must be confirmed in many patients. Therefore, the demand for epigenetics solutions is expected to rise in the oncology segment. These factors will drive the growth of the segment during the forecast period.
Which are the Key Regions for the Epigenetics Market?
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to account for 40% of the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The rising incidence of chronic diseases, increasing healthcare expenditure, and the presence of key vendors are leading to a rise in the use of epigenetics in North America. Leading biotechnology and life sciences companies export epigenetics instruments to other regions, such as Asia and South America. The large number of clinical trials is also driving the demand for epigenetics across North America.
This report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. COVID-19 led to supply chain and market disruptions for epigenetics consumables and instruments, which adversely impacted the regional market growth in 2020. However, the increasing adoption of genome sequencing technology for monitoring the spread of COVID-19 and the rising healthcare expenditure globally are boosting the demand for epigenetics solutions. Moreover, operations in the market were resumed after mass vaccination drives and ease of lockdown measures. These factors are expected to boost the growth of the epigenetics market in North America during the forecast period.
Segment Overview
The report forecasts market growth by revenue at global, regional, and country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
- Application Outlook (USD Million, 2017 - 2027)
- Oncology
- Non-oncology
- Product Outlook (USD Million, 2017 - 2027)
- Reagents
- Kits
- Others
- Region Outlook (USD Million, 2017 - 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- ROW
- Australia
- Argentina
- Rest of the world
- North America
Parent Market Analysis
The reports categorize the global epigenetics market as a part of the life sciences tools & services market, which covers products and companies engaged in R&D of a variety of product categories, including capital equipment, instruments, accessories, and consumables. It also covers life sciences-related services, including contract research, contract manufacturing, and contract sales. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.
|
Epigenetics Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
163 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 14.06% |
|
Market growth 2023-2027 |
USD 1,148.2 million |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
12.85 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 40% |
|
Key countries |
US, Canada, Germany, UK, and China |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abcam plc, Active Motif Inc., Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., BioVision Inc., CellCentric Ltd., Enzo Biochem Inc., EpiGentek Group Inc., F. Hoffmann La Roche Ltd., Hologic Inc., Illumina Inc., Merck KGaA, New England Biolabs Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., and Zymo Research Corp. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Epigenetics Market Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the epigenetics market between 2023 and 2027
- Precise estimation of the size of the epigenetics market and its contribution to the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of epigenetics market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global epigenetics market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global epigenetics market 2017 - 2021 ($ million)
- 4.2 Application Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)
- 4.3 Product Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application
- 6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
- 6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application
- 6.3 Oncology - Market size and forecast 2022-2027
- Exhibit 34: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
- 6.4 Non-oncology - Market size and forecast 2022-2027
- Exhibit 38: Chart on Non-oncology - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Non-oncology - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Non-oncology - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Non-oncology - Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Application
- Exhibit 42: Market opportunity by Application ($ million)
- Exhibit 43: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Product
- 7.1 Market segments
- Exhibit 44: Chart on Product - Market share 2022-2027 (%)
- Exhibit 45: Data Table on Product - Market share 2022-2027 (%)
- 7.2 Comparison by Product
- Exhibit 46: Chart on Comparison by Product
- Exhibit 47: Data Table on Comparison by Product
- 7.3 Reagents - Market size and forecast 2022-2027
- Exhibit 48: Chart on Reagents - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Reagents - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Reagents - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Reagents - Year-over-year growth 2022-2027 (%)
- 7.4 Kits - Market size and forecast 2022-2027
- Exhibit 52: Chart on Kits - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Kits - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Kits - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Kits - Year-over-year growth 2022-2027 (%)
- 7.5 Others - Market size and forecast 2022-2027
- Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%)
- 7.6 Market opportunity by Product
- Exhibit 60: Market opportunity by Product ($ million)
- Exhibit 61: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2022-2027 (%)
- Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 Germany - Market size and forecast 2022-2027
- Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.9 UK - Market size and forecast 2022-2027
- Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
- 9.10 Canada - Market size and forecast 2022-2027
- Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
- 9.11 China - Market size and forecast 2022-2027
- Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 108: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 109: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification
- 12.3 Abcam plc
- Exhibit 111: Abcam plc - Overview
- Exhibit 112: Abcam plc - Product / Service
- Exhibit 113: Abcam plc - Key news
- Exhibit 114: Abcam plc - Key offerings
- 12.4 Active Motif Inc.
- Exhibit 115: Active Motif Inc. - Overview
- Exhibit 116: Active Motif Inc. - Product / Service
- Exhibit 117: Active Motif Inc. - Key offerings
- 12.5 Agilent Technologies Inc.
- Exhibit 118: Agilent Technologies Inc. - Overview
- Exhibit 119: Agilent Technologies Inc. - Business segments
- Exhibit 120: Agilent Technologies Inc. - Key news
- Exhibit 121: Agilent Technologies Inc. - Key offerings
- Exhibit 122: Agilent Technologies Inc. - Segment focus
- 12.6 Bio Rad Laboratories Inc.
- Exhibit 123: Bio Rad Laboratories Inc. - Overview
- Exhibit 124: Bio Rad Laboratories Inc. - Business segments
- Exhibit 125: Bio Rad Laboratories Inc. - Key news
- Exhibit 126: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 127: Bio Rad Laboratories Inc. - Segment focus
- 12.7 BioVision Inc.
- Exhibit 128: BioVision Inc. - Overview
- Exhibit 129: BioVision Inc. - Product / Service
- Exhibit 130: BioVision Inc. - Key offerings
- 12.8 EpiGentek Group Inc.
- Exhibit 131: EpiGentek Group Inc. - Overview
- Exhibit 132: EpiGentek Group Inc. - Product / Service
- Exhibit 133: EpiGentek Group Inc. - Key offerings
- 12.9 F. Hoffmann La Roche Ltd.
- Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
- 12.10 Hologic Inc.
- Exhibit 139: Hologic Inc. - Overview
- Exhibit 140: Hologic Inc. - Business segments
- Exhibit 141: Hologic Inc. - Key news
- Exhibit 142: Hologic Inc. - Key offerings
- Exhibit 143: Hologic Inc. - Segment focus
- 12.11 Illumina Inc.
- Exhibit 144: Illumina Inc. - Overview
- Exhibit 145: Illumina Inc. - Business segments
- Exhibit 146: Illumina Inc. - Key news
- Exhibit 147: Illumina Inc. - Key offerings
- Exhibit 148: Illumina Inc. - Segment focus
- 12.12 Merck KGaA
- Exhibit 149: Merck KGaA - Overview
- Exhibit 150: Merck KGaA - Business segments
- Exhibit 151: Merck KGaA - Key news
- Exhibit 152: Merck KGaA - Key offerings
- Exhibit 153: Merck KGaA - Segment focus
- 12.13 New England Biolabs Inc.
- Exhibit 154: New England Biolabs Inc. - Overview
- Exhibit 155: New England Biolabs Inc. - Product / Service
- Exhibit 156: New England Biolabs Inc. - Key news
- Exhibit 157: New England Biolabs Inc. - Key offerings
- 12.14 Perkin Elmer Inc.
- Exhibit 158: Perkin Elmer Inc. - Overview
- Exhibit 159: Perkin Elmer Inc. - Business segments
- Exhibit 160: Perkin Elmer Inc. - Key news
- Exhibit 161: Perkin Elmer Inc. - Key offerings
- Exhibit 162: Perkin Elmer Inc. - Segment focus
- 12.15 QIAGEN NV
- Exhibit 163: QIAGEN NV - Overview
- Exhibit 164: QIAGEN NV - Product / Service
- Exhibit 165: QIAGEN NV - Key news
- Exhibit 166: QIAGEN NV - Key offerings
- 12.16 Thermo Fisher Scientific Inc.
- Exhibit 167: Thermo Fisher Scientific Inc. - Overview
- Exhibit 168: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 169: Thermo Fisher Scientific Inc. - Key news
- Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus
- 12.17 Zymo Research Corp.
- Exhibit 172: Zymo Research Corp. - Overview
- Exhibit 173: Zymo Research Corp. - Product / Service
- Exhibit 174: Zymo Research Corp. - Key offerings
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 175: Inclusions checklist
- Exhibit 176: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 177: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 178: Research methodology
- Exhibit 179: Validation techniques employed for market sizing
- Exhibit 180: Information sources
- 13.5 List of abbreviations
- Exhibit 181: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Frequently Asked Questions?
- US
- Canada
- Germany
- UK
- China
- Rising epigenetic applications in non-oncology diseases
- Technological advances in life sciences industry
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Did you know?
Did you know?
Did you know?
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
